ZBH vs. LMAT
Compare and contrast key facts about Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ZBH or LMAT.
Correlation
The correlation between ZBH and LMAT is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ZBH vs. LMAT - Performance Comparison
Key characteristics
ZBH:
-0.80
LMAT:
0.28
ZBH:
-0.91
LMAT:
0.58
ZBH:
0.87
LMAT:
1.08
ZBH:
-0.44
LMAT:
0.34
ZBH:
-1.79
LMAT:
0.86
ZBH:
11.43%
LMAT:
11.12%
ZBH:
25.99%
LMAT:
34.59%
ZBH:
-65.03%
LMAT:
-75.69%
ZBH:
-43.34%
LMAT:
-24.33%
Fundamentals
ZBH:
$20.25B
LMAT:
$1.82B
ZBH:
$4.43
LMAT:
$1.97
ZBH:
23.11
LMAT:
40.83
ZBH:
1.27
LMAT:
2.07
ZBH:
2.66
LMAT:
8.03
ZBH:
1.63
LMAT:
5.12
ZBH:
$7.70B
LMAT:
$226.26M
ZBH:
$5.11B
LMAT:
$154.18M
ZBH:
$1.79B
LMAT:
$65.12M
Returns By Period
In the year-to-date period, ZBH achieves a -9.77% return, which is significantly higher than LMAT's -11.33% return. Over the past 10 years, ZBH has underperformed LMAT with an annualized return of -0.63%, while LMAT has yielded a comparatively higher 24.11% annualized return.
ZBH
-9.77%
-7.47%
-12.11%
-20.60%
-3.52%
-0.63%
LMAT
-11.33%
4.63%
-19.04%
9.54%
26.64%
24.11%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ZBH vs. LMAT — Risk-Adjusted Performance Rank
ZBH
LMAT
ZBH vs. LMAT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ZBH vs. LMAT - Dividend Comparison
ZBH's dividend yield for the trailing twelve months is around 1.01%, more than LMAT's 0.83% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZBH Zimmer Biomet Holdings, Inc. | 1.01% | 0.91% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% | 0.78% |
LMAT LeMaitre Vascular, Inc. | 0.83% | 0.69% | 0.99% | 1.09% | 0.88% | 0.94% | 0.95% | 1.18% | 0.69% | 0.71% | 0.93% | 1.83% |
Drawdowns
ZBH vs. LMAT - Drawdown Comparison
The maximum ZBH drawdown since its inception was -65.03%, smaller than the maximum LMAT drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for ZBH and LMAT. For additional features, visit the drawdowns tool.
Volatility
ZBH vs. LMAT - Volatility Comparison
The current volatility for Zimmer Biomet Holdings, Inc. (ZBH) is 14.50%, while LeMaitre Vascular, Inc. (LMAT) has a volatility of 17.81%. This indicates that ZBH experiences smaller price fluctuations and is considered to be less risky than LMAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ZBH vs. LMAT - Financials Comparison
This section allows you to compare key financial metrics between Zimmer Biomet Holdings, Inc. and LeMaitre Vascular, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ZBH vs. LMAT - Profitability Comparison
ZBH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.21B and revenue of 1.91B. Therefore, the gross margin over that period was 63.3%.
LMAT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, LeMaitre Vascular, Inc. reported a gross profit of 41.42M and revenue of 59.87M. Therefore, the gross margin over that period was 69.2%.
ZBH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported an operating income of 338.90M and revenue of 1.91B, resulting in an operating margin of 17.8%.
LMAT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, LeMaitre Vascular, Inc. reported an operating income of 12.63M and revenue of 59.87M, resulting in an operating margin of 21.1%.
ZBH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported a net income of 182.00M and revenue of 1.91B, resulting in a net margin of 9.5%.
LMAT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, LeMaitre Vascular, Inc. reported a net income of 11.01M and revenue of 59.87M, resulting in a net margin of 18.4%.